The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

Valneva has reported encouraging six-month safety and antibody persistence data from the multi-centre Phase II trial, VLA1553 ...

Valneva reports positive six-month data for Ixchiq in children, supporting a full dose approach ahead of a Phase 3 trial set ...

Any microbe, new or known, could cause an infection outbreak at any time. Researchers gear up to preemptively fight this ...

EmulsiPan is an oil-in-water emulsion adjuvant and is produced by nano-emulsification of squalene along with surfactants and buffers. Squalene is a naturally occurring biodegradable and biocompatible ...

The Trump administration Department of Health and Human Services has canceled a $766 million contract with Moderna to ...

In other WHA developments today, member states approved a 20% increase in assessed contributions to the WHO while endorsing its 2026-27 budget, which the WHO said comes on the heels of a similar ...

and supported by the Coalition for Epidemic Preparedness Innovations (CEPI), to advance the fight against the deadly haemorrhagic Lassa Fever and accelerate the development and future equitable ...

Expanded life science and industrial portfolio with six additional life science products in developmentAdvances toward ...

April 28, 2025--(BUSINESS WIRE)--VitriVax, Inc., a formulation technology company, announced a new grant of up to $5M from the Coalition for Epidemic Preparedness Innovations (CEPI). The grant ...

Meanwhile, we should consider how the speed of innovation has skyrocketed in pace over the last 50 years, let alone the last five. Now, the Coalition for Epidemic Preparedness Innovations (CEPI ...